title: Serum prolactin response to a D2 antagonist in narcoleptic and control canines.
authors.forename: S
authors.initials: S
authors.lastname: Nishino
authors.forename: J
authors.initials: J
authors.lastname: Arrigoni
authors.forename: L H
authors.initials: LH
authors.lastname: Sharp
authors.forename: J D
authors.initials: JD
authors.lastname: Shelton
authors.forename: W C
authors.initials: WC
authors.lastname: Dement
authors.forename: E
authors.initials: E
authors.lastname: Mignot
mesh_terms: D000818:Animals; D004283:Dog Diseases / Q000097:blood / Q000188:drug therapy*; D004285:Dogs; D065127:Dopamine D2 Receptor Antagonists; D004305:Dose-Response Relationship, Drug; D005260:Female; D007262:Infusions, Intravenous; D008297:Male; D009290:Narcolepsy / Q000097:blood / Q000188:drug therapy / Q000662:veterinary*; D011388:Prolactin / Q000097:blood*; D020891:Raclopride; D012457:Salicylamides / Q000627:therapeutic use*
chemical_list: D065127:Dopamine D2 Receptor Antagonists; D012457:Salicylamides; D020891:Raclopride; D011388:Prolactin